Citação norma APA

van der Maas, A., van den Bemt, B. J., Wolbink, G., van den Hoogen, F. H., van Riel, P. L., & den Broeder, A. A. (2012). Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: Results of an observational cohort study. BioMed Central.

Citação norma Chicago

van der Maas, Aatke, Bart JF van den Bemt, Gertjan Wolbink, Frank HJ van den Hoogen, Piet LCM van Riel, and Alfons A. den Broeder. Low Infliximab Serum Trough Levels and Anti-infliximab Antibodies Are Prevalent in Rheumatoid Arthritis Patients Treated With Infliximab in Daily Clinical Practice: Results of an Observational Cohort Study. BioMed Central, 2012.

Citação norma MLA

van der Maas, Aatke, et al. Low Infliximab Serum Trough Levels and Anti-infliximab Antibodies Are Prevalent in Rheumatoid Arthritis Patients Treated With Infliximab in Daily Clinical Practice: Results of an Observational Cohort Study. BioMed Central, 2012.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.